newsfilter
← Latest News
GlobeNewswire·

Autolus Therapeutics to Participate in the Jefferies Global Healthcare Conference

  • Autolus Therapeutics plc (Nasdaq: AUTL) will participate in the Jefferies Global Healthcare Conference in London from November 16-19, 2026.
  • CEO Dr. Christian Itin is scheduled to present on Tuesday, November 17, 2026, at 8:30am EST / 1:30pm GMT.
  • A webcast of the presentation will be available on the "Events" page of the Company's Investor Relations & Media website.
  • The webcast replay will be archived on the Company's website for 90 days following the presentation.
  • Autolus is a commercial-stage biopharmaceutical company developing next-generation T cell therapies for cancer & autoimmune diseases.
  • The Company utilizes proprietary modular T cell programming technologies to engineer targeted therapies for hematological malignancies, solid tumors, & autoimmune diseases.
  • Amanda Cray is the designated contact for the Company at +1 617-967-0207 or a.cray@autolus.com.
Company
Autolus Inc.
Keywords
Nasdaq:AUTL, Autolus Inc., Dr Christian Itin, Autolus Therapeutics, AUTL